These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 912950)

  • 1. Characterization of Tx, an active subfraction of human dialyzable transfer factor. I. Identification of the major component in TFg, a precursor of Tx, as hypoxanthine.
    Wilson GB; Welch TM; Knapp DR; Horsmanheimo A; Fudenberg HH
    Clin Immunol Immunopathol; 1977 Nov; 8(3):551-68. PubMed ID: 912950
    [No Abstract]   [Full Text] [Related]  

  • 2. The identification and significance of hypoxanthine in dialyzable transfer factor.
    Kirkpatrick CH; Robinson LB; Smith TK
    Cell Immunol; 1976 Jun; 24(2):230-40. PubMed ID: 181148
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of hypoxanthine as the major compoenet of a chromatographic fraction of transfer factor.
    O'Dorisio MS; Neidhart JA; Daniel FB; Balcerzak SP; LoBuglio AF
    Cell Immunol; 1976 May; 23(2):191-202. PubMed ID: 1277303
    [No Abstract]   [Full Text] [Related]  

  • 4. Transfer factor: hypoxanthine is a major component of a fraction with in vivo activity.
    Tomar RH; Knight R; Stern M
    J Allergy Clin Immunol; 1976 Jul; 58(1 PT. 2):190-7. PubMed ID: 956555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfer factor (TFd). Part I. Some physicochemical data.
    Komorowska-Rycerz A; Szczypiorska D; Izdebska-Szymona K; Kociński W; Zarzycka A; Rzucidło L
    Mater Med Pol; 1979; 11(4):317-9. PubMed ID: 553982
    [No Abstract]   [Full Text] [Related]  

  • 6. Isolation and characterization of immunopeptide from dialyzable leukocyte extract.
    Khan A; Garrison O; Hill JM; Antonetti A; Hill NO; Gracy RW
    Cell Immunol; 1980 Oct; 55(2):420-7. PubMed ID: 7428052
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of dialyzable leukocyte extracts with transfer factor activity on leukocyte migration in vitro. V. Antigen-specific lymphocyte responsiveness can be initiated by two structurally distinct polyribonucleopeptides.
    Wilson GB; Paddock GV; Fudenberg HH
    Thymus; 1981 Feb; 2(4-5):257-6. PubMed ID: 6165106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct components in dialyzable leukocyte extracts (DLE) have specific and nonspecific effects on cellular immunity as shown by leukocyte migration inhibition.
    Wilson GB; Fudenberg HH; Bahm VJ
    Trans Assoc Am Physicians; 1978; 91():295-332. PubMed ID: 754397
    [No Abstract]   [Full Text] [Related]  

  • 9. Biochemical analysis of dialyzable leukocyte extracts.
    Gottlieb AA; Saito K; Sutcliffe S; Foster LA; Tamaki N; Maziarz G; Sutherland C; Brennessel B
    J Reticuloendothel Soc; 1977 Jun; 21(6):403-16. PubMed ID: 886545
    [No Abstract]   [Full Text] [Related]  

  • 10. Detection of "dialyzable transfer factor" in vitro: structural and chemical characterization of the activity specific for tuberculin.
    Wilson GB; Fudenberg HH; Paddock GV
    Ann N Y Acad Sci; 1979; 332():579-90. PubMed ID: 294834
    [No Abstract]   [Full Text] [Related]  

  • 11. Tx: a component in human dialyzable transfer factor that induces cutaneous delayed hypersensitivity in guinea pigs.
    Wilson GB; Welch TM; Fudenberg HH
    Clin Immunol Immunopathol; 1977 Mar; 7(2):187-202. PubMed ID: 862252
    [No Abstract]   [Full Text] [Related]  

  • 12. Bovine seminal plasma contains factors that enhance lymphocyte transformation in vitro.
    Lugaro G; Ornago E; Pagani F; De Angelis L; Giavarini F; Rosso di San Secondo
    Arch Androl; 1995; 34(3):141-50. PubMed ID: 7625877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guinea pig transfer factor: restriction of macrophage migration inhibitory activity to extraordinary dilution confirmed with demonstration of diminished potency of stored preparations.
    Whitacre CC; Paterson PY
    Clin Immunol Immunopathol; 1979 Jul; 13(3):287-95. PubMed ID: 88292
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of dialyzable leukocyte extracts (DLEs) with transfer factor activity on leukocyte migration in vitro. III. Characterization of the antigen-independent migration inhibition factor in DLEs as a neutrophil immobilizing factor.
    Wilson GB; Smith CL; Fudenberg HH
    J Allergy Clin Immunol; 1979 Jul; 64(1):56-66. PubMed ID: 447952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfer factor: specific and nonspecific effects and chemical characteristics of dialyzable leukocyte lysates (DLL). Part III. Biochemical characterization. (third of three parts).
    Ablin RJ
    Allergol Immunopathol (Madr); 1980; 8(3):203-12. PubMed ID: 7405767
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter: Uracil in transfer factor.
    Krohn KJ; Uotila A; Gröhn P; Väisänen J
    Lancet; 1975 Dec; 2(7946):1209. PubMed ID: 53691
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization of human dialyzable transfer factor from normal and chronic lymphoid leukemia sources.
    Goust JM; Marescot MR; Lesourd B; Doumercq S; Moulias R
    Biomedicine; 1976 Jan; 24(1):39-44. PubMed ID: 817750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Separation of beta2-microglobulin from transfer factor in dialyzable leukocyte extracts.
    Nékám K; Kelemen GS; Varró R; Fekete B; Láng I; Kalmár L; Gergely P; Petrányi G
    Allerg Immunol (Leipz); 1978; 24(4):254-8. PubMed ID: 84525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the chemical composition and biological properties of transfer factor.
    Krohn K; Uotila A; Väisänen J; Gröhn P
    Z Immunitatsforsch Immunobiol; 1977 Dec; 153(5):395-411. PubMed ID: 602344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on the mechanisms of tuberculin hypersensitivity. II. Non-dialyzable transfer factor (author's transl)].
    Oyamaguchi A
    Kekkaku; 1982 Apr; 57(4):225-32. PubMed ID: 7109421
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.